Genome Biologics
Genome Biologics
  • Home
  • TrueCardium®
  • Services
  • Disease models
  • Publications
  • Press & Blog
  • About
  • Contact us
  • Horizon 2020
  • More
    • Home
    • TrueCardium®
    • Services
    • Disease models
    • Publications
    • Press & Blog
    • About
    • Contact us
    • Horizon 2020
  • Home
  • TrueCardium®
  • Services
  • Disease models
  • Publications
  • Press & Blog
  • About
  • Contact us
  • Horizon 2020

Publications

1. Targeting miRNA-1a and miRNA-15b: A Novel Combinatorial Strategy to Drive Adult Cardiac  

    Regeneration. Adv Sci (Weinh), e2414455 (2025).

2. Human heart organoids reveal a regenerative strategy for mitochondrial disease. bioRxiv, 

    2025.2012.2018.695153 (2025).

3. Aging impairs the neurovascular interface in the heart. Science (New York, N.Y 381, 897-

    906 (2023).

4. The lncRNA Sweetheart regulates compensatory cardiac hypertrophy after myocardial injury in 

    murine males. Nature Communications 14, 7024 (2023).

5. The endothelial-enriched lncRNA LINC00607 mediates angiogenic function. Basic Research in 

    Cardiology 118, 5 (2023). 

6. A human cell atlas of the pressure-induced hypertrophic heart. Nature Cardiovascular Research 1, 

    174-185 (2022). 

7. Novel SARS-CoV-2 variants induce higher toxicity in cardiovascular cells. European Heart Journal 

    42 (2021). 

8. Mitochondrial–cell cycle cross-talk drives endoreplication in heart disease. Science Translational 

    Medicine 13 (2021). 

9. Dissection of heterocellular cross-talk in vascularized cardiac tissue mimetics. Journal of Molecular 

    and Cellular Cardiology138, 269-282 (2020). 

10. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovascular 

      Research 116, 2207-2215 (2020). 

Copyright © 2026 Genome Biologics – Human Cardiac Organoid Platform | TrueCardium® - All Rights Reserved.

  • Privacy Policy

Powered by

This site uses cookies.

We use cookies to analyze website traffic and to optimize your user experience for this website. If you accept cookies, your data will be merged with that of other users.

ACCEPT